Skip to main navigation Skip to search Skip to main content

Double-blind, placebo-controlled, randomised, parallel-group study, investigate the safety, tolerability and anxiolytic effect of the mGluR5 negative allosteric modulator ADX10059 in patients with dental anxiety undergoing dental treatment

  • Fairbrother, Kevin (Principal Investigator)
  • Lumley, Phil (Co-Investigator)

Project Details

Short titleDouble-blind, placebo-controlled, randomised, parallel-group study, investigate the safety, tolerability and anxiolytic effect of the mGluR5 negative allosteric modulator ADX10059 in patients with dental anxiety undergoing dental treatment
StatusFinished
Effective start/end date1/04/07 → 30/09/07

Funding

  • Addex Pharma SA